News

UCB, a global biopharmaceutical company, announced the detailed results of the head-to-head Phase 3 BE SURE study, which demonstrated that patients treated with investigational IL-17A and IL-17F inhibitor bimekizumab achieved superior skin clearance, as compared to adalimumab, in adults...

Roche announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy. “Tecentriq in combination with Avastin...

Novavax has spent much of 2020 advancing its COVID-19 vaccine candidate through early-stage testing and preparing for manufacturing and distribution. And thanks to the promise of that vaccine and a separate flu program, the company is expanding its Maryland...

The Lokmanya Tilak General Hospital, also known as Sion Hospital, will soon start phase-3 clinical trials of India’s indigenous Covid-19 vaccine—COVAXINTM. As many as 1,000 volunteers between the age of 18 and 60 years will participate in the trial. Currently,...

South African pharmaceutical company Aspen Pharmacare on Tuesday announced its deal with the American firm Johnson & Johnson to jointly manufacture its COVID-19 vaccine candidate ‘Ad26.COV3-S’. The manufacture of the vaccine is subject to its approval internationally and in...

German vaccine maker CureVac on Monday said that interim results from early trials showed that its investigational Covid-19 vaccine candidate, CvnCoV, appeared safe and triggered immune response among volunteers. The vaccine candidate was generally well tolerated across all tested doses...

The number of cases of the coronavirus disease (Covid-19) is nearing the 50 million mark across the world and the death toll has risen to more than 1.2 million, according to a worldometers tally, even as the global hunt...